Here's Why You Should Retain IQV Stock in Your Portfolio Now
Werte in diesem Artikel
IQVIA Holdings, Inc. IQV has gained 25.5% over the past three months compared with the industry’s 12.1% rise.The company has an expected long-term EPS (three to five years) growth rate of 8.38%. Earnings are expected to register year-over-year growth of 6.9% in 2025 and 8.4% in 2026. Image Source: Zacks Investment Research Factors That Augur Well for IQVIA’s SuccessIQVIA’s collaboration with Amazon Web Services ("AWS") strengthens its position at the intersection of life sciences and advanced AI. By naming AWS as its Preferred Agentic Cloud Provider, IQVIA secures access to a scalable, secure and mature cloud ecosystem that can accelerate clinical trial automation and advanced analytics. The partnership also strengthens IQVIA’s competitive moat, as most leading pharmaceutical companies already rely on both platforms. Over time, this alliance can improve operating efficiency, shorten drug development timelines and increase client stickiness, positioning IQVIA to benefit from the growing adoption of agentic AI across the healthcare and life sciences value chain.In the third quarter of 2025, IQV’s expanding R&DS backlog was $32.4 billion, up 4.1% year over year, which provides strong revenue visibility, with $8.1 billion expected to convert to revenues over the next 12 months.Book-to-bill ratios remained healthy, with 1.15X in the third quarter and 1.12X on a trailing-12-month basis, indicating that bookings continue to outpace revenue recognition and support future growth. In addition, net new bookings of $2.6 billion and 13% year-over-year growth in R&DS net bookings, alongside 20% year-over-year growth in RFP activity, point to strengthening client demand and improving decision timelines. These trends reinforce confidence in sustained revenue momentum into 2026.The company has demonstrated a strong commitment to returning value to its shareholders through an active share repurchase program. In 2024, IQV repurchased shares worth $1.35 billion. Over the nine-month period ending in 2025, the company has repurchased shares worth $1.03 billion. This substantial buyback not only lowers the total outstanding share count and boosts earnings per share (EPS) but also signals management's belief in the intrinsic value of the stock.IQV’s Key Risks to WatchIQV is facing significant challenges from weak liquidity. The company’s current ratio (a measure of liquidity) is consistently falling, declining from 1.12 in 2020 to 0.91 in 2021 and 0.89 in 2022, reflecting tightening working capital. The ratio slipped further to 0.86 in 2023 and 0.84 in 2024, before dropping sharply to 0.70 in the third quarter of 2025, underscoring growing pressure on short-term financial flexibility and a heavier reliance on cash flow to meet near-term obligations. A current ratio of less than one is considered undesirable as it indicates that the company does not have sufficient cash to meet its short-term obligations.IQV’s Zacks RankIQV currently carries a Zacks Rank of #3 (Hold).Stocks to ConsiderA couple of better-ranked stocks are Byrna Technologies BYRN and Veralto Corporation VLTO.Byrna Technologies currently carries a Zacks Rank of 2 (Buy). BYRN has an expected earnings growth rate of 25.8% and 33.3% for 2025 and 2026, respectively. BYRN has an encouraging earnings surprise history as it has surpassed the Zacks Consensus Estimate in the trailing four quarters, delivering an average earnings surprise of 167.5%.Veralto Corporation carries a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.VLTO has expected earnings growth rates of 8.5% and 9.2% for 2025 and 2026, respectively. The company has an encouraging earnings surprise history as it has surpassed the Zacks Consensus Estimate in the trailing four quarters, delivering an average earnings surprise of 6.5%.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IQVIA Holdings Inc. (IQV): Free Stock Analysis Report Byrna Technologies Inc. (BYRN): Free Stock Analysis Report Veralto Corporation (VLTO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: NOW und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf NOW
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NOW
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks